Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Novartis AG published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 100
» View wsbtradio.com items only
    Apr 16, 2012 |Story| WSBT Radio
  1. Kanye West Sick of "Theraflu," Changes Song Title to "Way Too Cold"

    Maybe "Theraflu" just had way too many bad symptoms associated with it.
    Maybe "Theraflu" just had way too many bad symptoms associated with it. Kanye West has changed the title of his controversial new song following a backlash from the manufacturer of the drug it's named after, who slammed the rapper for inappropriately...

    Tags: Music, People for the Ethical Treatment of Animals, Kim Kardashian, Kanye West, Entertainment

  2. May 23, 2013 |Story| Reuters
  3. RPT-FEATURE-Pfizer takes its shot at a vaccine for evasive superbug

    Reuters
    By Julie Steenhuysen CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year...

    Tags: Hospitals and Clinics, Chemical Industry, Health and Safety at School, Merck & Company Incorporated, Nabi

  4. May 22, 2013 |Story| Reuters
  5. Immune system cancer drugs tipped to be a $35 bln market

    Reuters
    * Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...

    Tags: AstraZeneca Plc, Weather, Amgen Inc., Science and Technology, Merck & Company Incorporated

  6. May 22, 2013 |Story| Reuters
  7. Immune system cancer drugs tipped to be a $35 billion market

    Reuters
    LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year. That bullish sales forecast by analysts at U.S. bank...

    Tags: AstraZeneca Plc, Weather, Science and Technology, Amgen Inc., Medical Research

  8. May 22, 2013 |Story| Reuters
  9. Inmunoterapia contra el cáncer podría ser un mercado de 35.000 mln dlrs anuales

    Reuters
    Por Ben Hirschler LONDRES, 22 may (Reuters) - Una nueva ola de medicinas que emplea el poder del sistema inmunológico para luchar contra el cáncer podría convertirse en el mayor grupo de medicamentos de la historia, con ventas potenciales de 35.000...

    Tags: AstraZeneca Plc, Amgen Inc., Citigroup Incorporated, Merck & Company Incorporated, Roche Holding AG

  10. May 16, 2013 |Story| Reuters
  11. Deals of the day -- mergers and acquisitions

    Reuters
    May 16 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** DDR Corp, owner of shopping centers where big-box retailers are located, said on Wednesday it had agreed to buy from Blackstone Group LP...

    Tags: Chemical Industry, Germany, Drugs and Medicines, Blackstone Group, L.P., Finance

  12. May 16, 2013 |Story| Reuters
  13. Novartis says has no intention of buying Actavis

    Reuters
    ZURICH, May 16 (Reuters) - Novartis has no plans to bid for U.S.-based generic drugmaker Actavis, which is the subject of intense takeover speculation, a spokesman for the Swiss drugmaker said on Thursday. "We have no intention to pursue them," spokesman...

    Tags: The Wall Street Journal

  14. May 16, 2013 |Story| Reuters
  15. DEALTALK-Novartis' Vasella exit opens door to Roche stake sale

    Reuters
    * Novartis' one-third stake in Roche built up under Vasella * Vasella exit, retirement of Roche chairman could thaw relations * Roche seen as most likely buyer for the stake * Could make offer in second half of this year - analyst By Caroline...

    Tags: Politics, Genentech Inc., Zurich (Swiss Confederation), Merck & Company Incorporated, Drugs and Medicines

  16. May 15, 2013 |Story| Reuters
  17. Acciones europeas alcanzan máximo 5 años impulsadas por papeles suizos

    Reuters
    Por Sudip Kar-Gupta LONDRES, 15 mayo (Reuters) - Las acciones europeas treparon el miércoles a nuevos máximos de cinco años, lideradas por los avances de papeles suizos tras un retroceso del franco suizo que debería continuar beneficiando a los...
  18. May 15, 2013 |Story| Reuters
  19. SEC says new settlements end 'Golden Goose' insider trading case

    Reuters
    * Jamil Bouchareb, Daniel Corbin settle civil cases * Tips said to be misappropriated from PR firm executive May 15 (Reuters) - The U.S. Securities and Exchange Commission on Wednesday said it has reached settlements with the last two defendants in an...

    Tags: Prisons, Electronic Arts Inc., Trials, Lehman Brothers Holdings Inc., Punishment

  20. May 15, 2013 |Story| Reuters
  21. Swiss stocks push European shares to fresh peaks

    Reuters
    LONDON, May 15 (Reuters) - European shares scaled fresh five-year highs on Wednesday, led by gains for several major Swiss stocks after a currency shift that should continue to buoy the country's exporters. The pan-European FTSEurofirst 300 index...

    Tags: Credit Ratings, Exports, Central Bank

  22. May 15, 2013 |Story| Reuters
  23. Acciones europeas cierran en alza, alcanzan máximo 5 años

    Reuters
    LONDRES (Reuters) - Las acciones europeas treparon el miércoles a nuevos máximos de cinco años, lideradas por los avances de papeles suizos tras un retroceso del franco suizo que debería continuar beneficiando a los exportadores de ese origen. El í...
 1  2 3 4 5 6 7 8 9Next >
Original site for Novartis AG topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Novartis AG Photos
Novartis headquarters in Basel, Switzerland.
(April 26, 2013)
Novartis headquarters
Barbara Kittridge has been appointed chief marketing of...
(January 10, 2013)
Barbara Kittridge, chief marketing officer, Cardinal Path Inc.
Steve Auten has joined Cozen O'Connor as a member of th...
(September 5, 2012)
Steve Auten, partner, Cozen O'Connor